Professor and Head of the Department Univeristy of Arizona
Radiation Oncology
Dr. Baldassarre Stea, MD
|
|
Give Review
Doctor Baldassarre Stea, MD works in the field of Radiation Oncology. He went to George Washington University School of Medicine. George Washington University School of Medicine is ranked 67 in research and 0 in primary care medicine He received awards:"America's Top Doctors", "Top Doctors:Arizona State" and "America's Top Doctors for Cancer". Baldassarre Stea is a published doctor and has 32 publications published. The lastest was: 'Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high risk limited stage aggressive B-cell lymphoma: SWOG S0313.' Dr. Baldassarre Stea accepts Medicare.
Publications
- Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high risk limited stage aggressive B-cell lymphoma: SWOG S0313.
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer.
- Clinically relevant biomarkers in targeted radiotherapy.
- Medulloblastoma with extensive nodularity undergoing post-therapeutic maturation to a gangliocytoma: a case report and literature review.
- Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
- The role of radiation therapy in the control of locoregional and metastatic Cancer.
- GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
- c-erbB-2 protein level in tissue and sera of breast Cancer patients: a possibly useful clinical correlation.
- GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
- Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
- Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
- Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-...
- Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral Cancer.
- Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal Cancer patients and healthy controls.
- Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 (''Iressa'').
- RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Meta...
- Primary T-cell lymphoma of the breast: a case report.
- Gonadotropin releasing hormone receptor expression in primary breast Cancer: comparison of immunohistochemical, radioligand and Western blot analyses.
- Radiation recall dermatitis from high-dose interferon alfa-2b.
- IGFBP2 promotes glioma tumor stem cell expansion and survival.
- Whole-brain radiation therapy in melanoma: an open question.
- Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung Cancer: clinical implications.
- The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.
- Biological role of NHERF1 protein expression in breast Cancer.
- Rad51 protein expression and survival in patients with glioblastoma multiforme.
- Stereotactic radiotherapy for unilateral orbital lymphoma and orbital pseudo-tumors: a planning study.
- Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System.
- Patient positioning using implanted gold markers with the Novalis Body system in the thoracic spine.
- Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Gr...
- Improved survival, quality of life, and quality-adjusted survival in breast Cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for...
- alpha6 integrin cleavage: sensitizing human prostate Cancer to ionizing radiation.
Schools
George Washington University School Of Medicine
George Washington University Med Center
National Canc Institute
Conditions Treated
- Pituitary Gland Cancer
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Arizona State
- America's Top Doctors for Cancer
Education
-
National Institutes of Health Clinical Center -
George Washington University -
George Washington University School of Medicine
Drug Facts
| NPI NUMBER | 1003988247 | |
| NPPES Provider LastName | STEA | |
| NPPES Provider FirstName | BALDASSARRE | |
| NPPES Provider ZIPCode | 857240001 | |
| NPPES Provider State | AZ | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 116.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003988247 |
| Last Name Of The Provider | STEA |
| First Name Of The Provider | BALDASSARRE |
| View All |
Similar Doctors
|
|
Dr. David A. Frye, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa J. Hazard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deirdre Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor J. Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marilyn K. Croghan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael K. Cheung, MD |
|
|
Dr. Edward E. Rogoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anand B. Desai, MD |
|
|
Dr. Steven E. Sckolnik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sun K. Yi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David T. VonK, MD
This Doctor is OpenDoctor Recommended.
|